Energy-based non-invasive medical aesthetic treatment system market size is set to grow at a CAGR of 11.11% by 2027, Growth led by Bausch Health Co Inc., Boston Scientific Corp., among others – Technavio

The energy-based non-invasive medical aesthetic treatment system market report has been published by Technavio. Market growth is estimated to accelerate at a CAGR of 11.11% and register an incremental growth of USD 1,841.74 million during the forecast period. The report also includes historic market data from 2017 to 2021. In 2017, the energy-based non-invasive medical aesthetic treatment system market was valued at USD 1,644.21 million. The report provides a comprehensive analysis of growth opportunities at regional levels, new product launches, the latest trends, and the post-pandemic recovery of the global market. Download a PDF sample report

Technavio has announced its latest market research report titled Global Energy-based Non-invasive Medical Aesthetic Treatment System Market 2023-2027
Technavio has announced its latest market research report titled Global Energy-based Non-invasive Medical Aesthetic Treatment System Market 2023-2027

Regional analysis

Based on region, the global energy-based non-invasive medical aesthetic treatment system market is segmented into North America, Europe, Asia, and Rest of World (ROW). North America is estimated to account for 46% of the growth of the global market over the forecast period. The high awareness and the increasing adoption of energy-based non-invasive medical aesthetic treatments are driving the growth of the regional market.

Company profiles

The energy-based non-invasive medical aesthetic treatment system market report includes information on the key products and recent developments of leading vendors, including:

  • Bausch Health Co Inc.: The company offers energy-based non-invasive medical aesthetic treatment systems such as gastrointestinal diseases and aesthetic devices, and small appliances.
  • Boston Scientific Corp.: The company offers energy-based non-invasive medical aesthetic treatment systems such as cardiac resynchronization therapy pacemaker, defibrillators, left atrial appendage closure, pacemakers, and remote patient monitoring.
  • Candela Corp: The company offers energy-based non-invasive medical aesthetic treatment systems such as CO2RE, CO2RE intima, and profound.
  • Cutera Inc.: The company offers energy-based non-invasive medical aesthetic treatment systems such as truSculpt flex and truSculpt iD.
  • Cynosure LLC: The company offers energy-based non-invasive medical aesthetic treatment systems such as icon, monaLisa touch, and picoSure.
  • El.En. Spa.
  • Galderma SA
  • Hologic Inc.
  • INDIBA SA.
  • To gain access to more vendor profiles available with Technavio, Buy the report!

Market dynamics

The market is driven by factors such as the growing awareness about the availability of energy-based non-invasive medical aesthetic treatment systems, limited side effects associated with treatment, and initiatives on social media. However, the need for significant investments to offer energy-based non-invasive medical aesthetic treatment is hindering the market growth.

Competitive analysis

The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, among others. Request a sample

Market segmentation

  • Based on application, the energy-based non-invasive medical aesthetic treatment system market is segmented into skin rejuvenation, vaginal rejuvenation, hair removal, leg vein treatment, and others. 
  • Based on end-user, the market is segmented into medspa, hospitals and surgery centers, HCP-owned clinics, and traditional spa
  • Based on geography, the energy-based non-invasive medical aesthetic treatment system market is segmented into North America, Europe, Asia, and Rest of World (ROW).

Related Reports:

The non-invasive intracranial pressure monitoring devices market size is expected to increase by USD 125.89 millionfrom 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 6.02%. The growing awareness of non-invasive ICP monitoring devices is notably driving the non-invasive intracranial pressure monitoring devices market growth, although factors such as availability and use of invasive ICP monitoring devices may impede the market growth.

The non-invasive glucose monitoring devices market is estimated to grow at a CAGR of 15.68% between 2022 and 2027. The size of the market is forecasted to increase by USD 22.49 million. The increasing prevalence of diabetes and the growing number of government programs are notably driving the market growth, although factors such as high costs associated with non-invasive glucose monitoring devices may impede the market growth.

Technavio’s library includes over 17,000+ reports, covering more than 2,000 emerging technologies. Subscribe to our “Basic Plan” at just USD 5,000 and get lifetime access to Technavio Insights

What are the key data covered in this energy-based non-invasive medical aesthetic treatment system market report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the energy-based non-invasive medical aesthetic treatment system market between 2023 and 2027
  • Precise estimation of the energy-based non-invasive medical aesthetic treatment system market size and its contribution to the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the industry across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market’s competitive landscape and detailed information about vendors
  • Comprehensive analysis of factors that will challenge the growth of energy-based non-invasive medical aesthetic treatment system market vendors
Energy-based Non-invasive Medical Aesthetic Treatment System Market Scope
Report CoverageDetails
Page number172
Base year2022
Historic period2017-2021
Forecast period2023-2027
Growth momentum & CAGRAccelerate at a CAGR of 11.11%
Market growth 2023-2027USD 1,841.74 million
Market structureFragmented
YoY growth 2022-2023(%)9.34
Regional analysisNorth America, Europe, Asia, and Rest of World (ROW)
Performing market contributionNorth America at 46%
Key countriesUS, Japan, China, Germany, and UK
Competitive landscapeLeading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiledAbbVie Inc., Alma Lasers GmbH, AngioDynamics Inc., Bausch Health Co Inc., Boston Scientific Corp., Candela Corp, Cutera Inc., Cynosure LLC, El.En. Spa., Galderma SA, Hologic Inc., INDIBA SA., Lumenis Be Ltd, Mentor Plastic Surgery., Merz Pharma GmbH and Co KGaA, Prollenium Medical Technologies Inc., Sciton Inc., Suneva Medical, and Johnson and Johnson
Market dynamicsParent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.
Customization purviewIf our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse for Technavio health care market reports

Table of contents:

1 Executive Summary

  • 1.1 Market overview 
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem 
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition 
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis 
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027 
    • Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
    • Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
    • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
    • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global energy-based non-invasive medical aesthetic treatment system market 2017 – 2021 
    • Exhibit 18: Historic Market Size – Data table on global energy-based non-invasive medical aesthetic treatment system market 2017 – 2021 ($ million)
  • 4.2 Application Segment Analysis 2017 – 2021
    • Exhibit 19: Historic Market Size – Application Segment 2017 – 2021 ($ million)
  • 4.3 End-user Segment Analysis 2017 – 2021 
    • Exhibit 20: Historic Market Size – End-user Segment 2017 – 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 – 2021 
    • Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 – 2021 
    • Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary 
    • Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers 
    • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers 
    • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants 
    • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes 
    • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry 
    • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
  • 5.7 Market condition 
    • Exhibit 29: Chart on Market condition – Five forces 2022 and 2027

6 Market Segmentation by Application

  • 6.1 Market segments 
    • Exhibit 30: Chart on Application – Market share 2022-2027 (%)
    • Exhibit 31: Data Table on Application – Market share 2022-2027 (%)
  • 6.2 Comparison by Application 
    • Exhibit 32: Chart on Comparison by Application
    • Exhibit 33: Data Table on Comparison by Application
  • 6.3 Skin rejuvenation – Market size and forecast 2022-2027
    • Exhibit 34: Chart on Skin rejuvenation – Market size and forecast 2022-2027 ($ million)
    • Exhibit 35: Data Table on Skin rejuvenation – Market size and forecast 2022-2027 ($ million)
    • Exhibit 36: Chart on Skin rejuvenation – Year-over-year growth 2022-2027 (%)
    • Exhibit 37: Data Table on Skin rejuvenation – Year-over-year growth 2022-2027 (%)
  • 6.4 Vaginal rejuvenation – Market size and forecast 2022-2027
    • Exhibit 38: Chart on Vaginal rejuvenation – Market size and forecast 2022-2027 ($ million)
    • Exhibit 39: Data Table on Vaginal rejuvenation – Market size and forecast 2022-2027 ($ million)
    • Exhibit 40: Chart on Vaginal rejuvenation – Year-over-year growth 2022-2027 (%)
    • Exhibit 41: Data Table on Vaginal rejuvenation – Year-over-year growth 2022-2027 (%)
  • 6.5 Hair removal – Market size and forecast 2022-2027
    • Exhibit 42: Chart on Hair removal – Market size and forecast 2022-2027 ($ million)
    • Exhibit 43: Data Table on Hair removal – Market size and forecast 2022-2027 ($ million)
    • Exhibit 44: Chart on Hair removal – Year-over-year growth 2022-2027 (%)
    • Exhibit 45: Data Table on Hair removal – Year-over-year growth 2022-2027 (%)
  • 6.6 Leg vein treatment – Market size and forecast 2022-2027
    • Exhibit 46: Chart on Leg vein treatment – Market size and forecast 2022-2027 ($ million)
    • Exhibit 47: Data Table on Leg vein treatment – Market size and forecast 2022-2027 ($ million)
    • Exhibit 48: Chart on Leg vein treatment – Year-over-year growth 2022-2027 (%)
    • Exhibit 49: Data Table on Leg vein treatment – Year-over-year growth 2022-2027 (%)
  • 6.7 Others – Market size and forecast 2022-2027
    • Exhibit 50: Chart on Others – Market size and forecast 2022-2027 ($ million)
    • Exhibit 51: Data Table on Others – Market size and forecast 2022-2027 ($ million)
    • Exhibit 52: Chart on Others – Year-over-year growth 2022-2027 (%)
    • Exhibit 53: Data Table on Others – Year-over-year growth 2022-2027 (%)
  • 6.8 Market opportunity by Application 
    • Exhibit 54: Market opportunity by Application ($ million)

7 Market Segmentation by End-user

  • 7.1 Market segments 
    • Exhibit 55: Chart on End-user – Market share 2022-2027 (%)
    • Exhibit 56: Data Table on End-user – Market share 2022-2027 (%)
  • 7.2 Comparison by End-user 
    • Exhibit 57: Chart on Comparison by End-user
    • Exhibit 58: Data Table on Comparison by End-user
  • 7.3 Medspa – Market size and forecast 2022-2027
    • Exhibit 59: Chart on Medspa – Market size and forecast 2022-2027 ($ million)
    • Exhibit 60: Data Table on Medspa – Market size and forecast 2022-2027 ($ million)
    • Exhibit 61: Chart on Medspa – Year-over-year growth 2022-2027 (%)
    • Exhibit 62: Data Table on Medspa – Year-over-year growth 2022-2027 (%)
  • 7.4 Hospitals and surgery center – Market size and forecast 2022-2027 
    • Exhibit 63: Chart on Hospitals and surgery center – Market size and forecast 2022-2027 ($ million)
    • Exhibit 64: Data Table on Hospitals and surgery center – Market size and forecast 2022-2027 ($ million)
    • Exhibit 65: Chart on Hospitals and surgery center – Year-over-year growth 2022-2027 (%)
    • Exhibit 66: Data Table on Hospitals and surgery center – Year-over-year growth 2022-2027 (%)
  • 7.5 HCP owned clinic – Market size and forecast 2022-2027
    • Exhibit 67: Chart on HCP owned clinic – Market size and forecast 2022-2027 ($ million)
    • Exhibit 68: Data Table on HCP owned clinic – Market size and forecast 2022-2027 ($ million)
    • Exhibit 69: Chart on HCP owned clinic – Year-over-year growth 2022-2027 (%)
    • Exhibit 70: Data Table on HCP owned clinic – Year-over-year growth 2022-2027 (%)
  • 7.6 Traditional spa – Market size and forecast 2022-2027
    • Exhibit 71: Chart on Traditional spa – Market size and forecast 2022-2027 ($ million)
    • Exhibit 72: Data Table on Traditional spa – Market size and forecast 2022-2027 ($ million)
    • Exhibit 73: Chart on Traditional spa – Year-over-year growth 2022-2027 (%)
    • Exhibit 74: Data Table on Traditional spa – Year-over-year growth 2022-2027 (%)
  • 7.7 Market opportunity by End-user 
    • Exhibit 75: Market opportunity by End-user ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview 
    • Exhibit 76: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation 
    • Exhibit 77: Chart on Market share by geography 2022-2027 (%)
    • Exhibit 78: Data Table on Market share by geography 2022-2027 (%)
  • 9.2 Geographic comparison 
    • Exhibit 79: Chart on Geographic comparison
    • Exhibit 80: Data Table on Geographic comparison
  • 9.3 North America – Market size and forecast 2022-2027
    • Exhibit 81: Chart on North America – Market size and forecast 2022-2027 ($ million)
    • Exhibit 82: Data Table on North America – Market size and forecast 2022-2027 ($ million)
    • Exhibit 83: Chart on North America – Year-over-year growth 2022-2027 (%)
    • Exhibit 84: Data Table on North America – Year-over-year growth 2022-2027 (%)
  • 9.4 Europe – Market size and forecast 2022-2027
    • Exhibit 85: Chart on Europe – Market size and forecast 2022-2027 ($ million)
    • Exhibit 86: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
    • Exhibit 87: Chart on Europe – Year-over-year growth 2022-2027 (%)
    • Exhibit 88: Data Table on Europe – Year-over-year growth 2022-2027 (%)
  • 9.5 Asia – Market size and forecast 2022-2027
    • Exhibit 89: Chart on Asia – Market size and forecast 2022-2027 ($ million)
    • Exhibit 90: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
    • Exhibit 91: Chart on Asia – Year-over-year growth 2022-2027 (%)
    • Exhibit 92: Data Table on Asia – Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
    • Exhibit 93: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
    • Exhibit 94: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
    • Exhibit 95: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
    • Exhibit 96: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
  • 9.7 US – Market size and forecast 2022-2027
    • Exhibit 97: Chart on US – Market size and forecast 2022-2027 ($ million)
    • Exhibit 98: Data Table on US – Market size and forecast 2022-2027 ($ million)
    • Exhibit 99: Chart on US – Year-over-year growth 2022-2027 (%)
    • Exhibit 100: Data Table on US – Year-over-year growth 2022-2027 (%)
  • 9.8 Germany – Market size and forecast 2022-2027
    • Exhibit 101: Chart on Germany – Market size and forecast 2022-2027 ($ million)
    • Exhibit 102: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
    • Exhibit 103: Chart on Germany – Year-over-year growth 2022-2027 (%)
    • Exhibit 104: Data Table on Germany – Year-over-year growth 2022-2027 (%)
  • 9.9 Japan – Market size and forecast 2022-2027
    • Exhibit 105: Chart on Japan – Market size and forecast 2022-2027 ($ million)
    • Exhibit 106: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
    • Exhibit 107: Chart on Japan – Year-over-year growth 2022-2027 (%)
    • Exhibit 108: Data Table on Japan – Year-over-year growth 2022-2027 (%)
  • 9.10 UK – Market size and forecast 2022-2027 
    • Exhibit 109: Chart on UK – Market size and forecast 2022-2027 ($ million)
    • Exhibit 110: Data Table on UK – Market size and forecast 2022-2027 ($ million)
    • Exhibit 111: Chart on UK – Year-over-year growth 2022-2027 (%)
    • Exhibit 112: Data Table on UK – Year-over-year growth 2022-2027 (%)
  • 9.11 China – Market size and forecast 2022-2027
    • Exhibit 113: Chart on China – Market size and forecast 2022-2027 ($ million)
    • Exhibit 114: Data Table on China – Market size and forecast 2022-2027 ($ million)
    • Exhibit 115: Chart on China – Year-over-year growth 2022-2027 (%)
    • Exhibit 116: Data Table on China – Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity by geography 
    • Exhibit 117: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges 
    • Exhibit 118: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape 
    • Exhibit 119: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption 
    • Exhibit 120: Overview on factors of disruption
  • 11.4 Industry risks 
    • Exhibit 121: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered 
    • Exhibit 122: Vendors covered
  • 12.2 Market positioning of vendors 
    • Exhibit 123: Matrix on vendor position and classification
  • 12.3 Alma Lasers GmbH 
    • Exhibit 124: Alma Lasers GmbH – Overview
    • Exhibit 125: Alma Lasers GmbH – Product / Service
    • Exhibit 126: Alma Lasers GmbH – Key offerings
  • 12.4 Bausch Health Co Inc. 
    • Exhibit 127: Bausch Health Co Inc. – Overview
    • Exhibit 128: Bausch Health Co Inc. – Business segments
    • Exhibit 129: Bausch Health Co Inc. – Key news
    • Exhibit 130: Bausch Health Co Inc. – Key offerings
    • Exhibit 131: Bausch Health Co Inc. – Segment focus
  • 12.5 Boston Scientific Corp. 
    • Exhibit 132: Boston Scientific Corp. – Overview
    • Exhibit 133: Boston Scientific Corp. – Business segments
    • Exhibit 134: Boston Scientific Corp. – Key news
    • Exhibit 135: Boston Scientific Corp. – Key offerings
    • Exhibit 136: Boston Scientific Corp. – Segment focus
  • 12.6 Candela Corp 
    • Exhibit 137: Candela Corp – Overview
    • Exhibit 138: Candela Corp – Product / Service
    • Exhibit 139: Candela Corp – Key offerings
  • 12.7 Cutera Inc. 
    • Exhibit 140: Cutera Inc. – Overview
    • Exhibit 141: Cutera Inc. – Product / Service
    • Exhibit 142: Cutera Inc. – Key offerings
  • 12.8 Cynosure LLC 
    • Exhibit 143: Cynosure LLC – Overview
    • Exhibit 144: Cynosure LLC – Product / Service
    • Exhibit 145: Cynosure LLC – Key offerings
  • 12.9 El.En. Spa. 
    • Exhibit 146: El.En. Spa. – Overview
    • Exhibit 147: El.En. Spa. – Business segments
    • Exhibit 148: El.En. Spa. – Key offerings
    • Exhibit 149: El.En. Spa. – Segment focus
  • 12.10 Hologic Inc. 
    • Exhibit 150: Hologic Inc. – Overview
    • Exhibit 151: Hologic Inc. – Business segments
    • Exhibit 152: Hologic Inc. – Key news
    • Exhibit 153: Hologic Inc. – Key offerings
    • Exhibit 154: Hologic Inc. – Segment focus
  • 12.11 INDIBA SA. 
    • Exhibit 155: INDIBA SA. – Overview
    • Exhibit 156: INDIBA SA. – Product / Service
    • Exhibit 157: INDIBA SA. – Key offerings
  • 12.12 Johnson and Johnson 
    • Exhibit 158: Johnson and Johnson – Overview
    • Exhibit 159: Johnson and Johnson – Business segments
    • Exhibit 160: Johnson and Johnson – Key news
    • Exhibit 161: Johnson and Johnson – Key offerings
    • Exhibit 162: Johnson and Johnson – Segment focus
  • 12.13 Lumenis Be Ltd 
    • Exhibit 163: Lumenis Be Ltd – Overview
    • Exhibit 164: Lumenis Be Ltd – Product / Service
    • Exhibit 165: Lumenis Be Ltd – Key offerings
  • 12.14 Merz Pharma GmbH and Co KGaA 
    • Exhibit 166: Merz Pharma GmbH and Co KGaA – Overview
    • Exhibit 167: Merz Pharma GmbH and Co KGaA – Product / Service
    • Exhibit 168: Merz Pharma GmbH and Co KGaA – Key offerings
  • 12.15 Prollenium Medical Technologies Inc. 
    • Exhibit 169: Prollenium Medical Technologies Inc. – Overview
    • Exhibit 170: Prollenium Medical Technologies Inc. – Business segments
    • Exhibit 171: Prollenium Medical Technologies Inc. – Key offerings
    • Exhibit 172: Prollenium Medical Technologies Inc. – Segment focus
  • 12.16 Sciton Inc. 
    • Exhibit 173: Sciton Inc. – Overview
    • Exhibit 174: Sciton Inc. – Product / Service
    • Exhibit 175: Sciton Inc. – Key offerings
  • 12.17 Suneva Medical 
    • Exhibit 176: Suneva Medical – Overview
    • Exhibit 177: Suneva Medical – Product / Service
    • Exhibit 178: Suneva Medical – Key offerings

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist 
    • Exhibit 179: Inclusions checklist
    • Exhibit 180: Exclusions checklist
  • 13.3 Currency conversion rates for US$ 
    • Exhibit 181: Currency conversion rates for US$
  • 13.4 Research methodology 
    • Exhibit 182: Research methodology
    • Exhibit 183: Validation techniques employed for market sizing
    • Exhibit 184: Information sources
  • 13.5 List of abbreviations 
    • Exhibit 185: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio

Leave a Reply

Your email address will not be published. Required fields are marked *